HSPH1 and colorectal carcinoma: Studies in vitro and in vivo in CRC patients and colorectal cancer cells have shown that Hsp110 co-localizes with DNA damage and, in response to chemotherapy, is translocated to the nucleus, where it interacts with the non-homologous end-joining (NHEJ) repair machinery elements [197].